STERIS shares are trading higher after Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $230 to $260.
Portfolio Pulse from Benzinga Newsdesk
STERIS shares rose following an upgrade by Piper Sandler from Neutral to Overweight, with a price target increase from $230 to $260.
October 24, 2024 | 4:25 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
STERIS shares are trading higher after Piper Sandler upgraded the stock from Neutral to Overweight and increased the price target from $230 to $260.
The upgrade from Neutral to Overweight by Piper Sandler is a positive signal for investors, indicating increased confidence in STERIS's performance. The raised price target suggests potential for stock price appreciation, leading to a likely short-term increase in share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100